Global Orphan Drugs for Adults Supply, Demand and Key Producers, 2023-2029

Description

The global Orphan Drugs for Adults market size is expected to reach $ 105970 million by 2029, rising at a market growth of 9.2% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Orphan drugs for adults refer to medications that are specifically developed and approved for the treatment of rare diseases or conditions in adult populations. These drugs are designed to address medical needs in adult patients who have limited treatment options due to the rarity of their conditions.

This report studies the global Orphan Drugs for Adults demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Orphan Drugs for Adults, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Orphan Drugs for Adults that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Orphan Drugs for Adults total market, 2018-2029, (USD Million)
Global Orphan Drugs for Adults total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Orphan Drugs for Adults total market, key domestic companies and share, (USD Million)
Global Orphan Drugs for Adults revenue by player and market share 2018-2023, (USD Million)
Global Orphan Drugs for Adults total market by Type, CAGR, 2018-2029, (USD Million)
Global Orphan Drugs for Adults total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Orphan Drugs for Adults market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie, Orpharma, Amgen, Recordati, Novartis, Celgene, Amryt Pharma, Johnson & Johnson and GSK, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Orphan Drugs for Adults market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Orphan Drugs for Adults Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Orphan Drugs for Adults Market, Segmentation by Type
    Oncology Drugs
    Gastrointestinal Drugs
    Neurology Drugs
    Cardio-vascular Drugs
    Others

Global Orphan Drugs for Adults Market, Segmentation by Application
    Hospital Pharmacies
    Retail pharmacies
    Others

Companies Profiled:
    Abbvie
    Orpharma
    Amgen
    Recordati
    Novartis
    Celgene
    Amryt Pharma
    Johnson & Johnson
    GSK
    Bristol-Myers Squibb Company
    Roche Holding
    Sanofi
    Takeda
    Pfizer
    Vertex Pharmaceuticals

Key Questions Answered
1. How big is the global Orphan Drugs for Adults market?
2. What is the demand of the global Orphan Drugs for Adults market?
3. What is the year over year growth of the global Orphan Drugs for Adults market?
4. What is the total value of the global Orphan Drugs for Adults market?
5. Who are the major players in the global Orphan Drugs for Adults market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Orphan Drugs for Adults Introduction
    1.2 World Orphan Drugs for Adults Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Orphan Drugs for Adults Total Market by Region (by Headquarter Location)
        1.3.1 World Orphan Drugs for Adults Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Orphan Drugs for Adults Market Size (2018-2029)
        1.3.3 China Orphan Drugs for Adults Market Size (2018-2029)
        1.3.4 Europe Orphan Drugs for Adults Market Size (2018-2029)
        1.3.5 Japan Orphan Drugs for Adults Market Size (2018-2029)
        1.3.6 South Korea Orphan Drugs for Adults Market Size (2018-2029)
        1.3.7 ASEAN Orphan Drugs for Adults Market Size (2018-2029)
        1.3.8 India Orphan Drugs for Adults Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Orphan Drugs for Adults Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Orphan Drugs for Adults Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Orphan Drugs for Adults Consumption Value (2018-2029)
    2.2 World Orphan Drugs for Adults Consumption Value by Region
        2.2.1 World Orphan Drugs for Adults Consumption Value by Region (2018-2023)
        2.2.2 World Orphan Drugs for Adults Consumption Value Forecast by Region (2024-2029)
    2.3 United States Orphan Drugs for Adults Consumption Value (2018-2029)
    2.4 China Orphan Drugs for Adults Consumption Value (2018-2029)
    2.5 Europe Orphan Drugs for Adults Consumption Value (2018-2029)
    2.6 Japan Orphan Drugs for Adults Consumption Value (2018-2029)
    2.7 South Korea Orphan Drugs for Adults Consumption Value (2018-2029)
    2.8 ASEAN Orphan Drugs for Adults Consumption Value (2018-2029)
    2.9 India Orphan Drugs for Adults Consumption Value (2018-2029)

3 World Orphan Drugs for Adults Companies Competitive Analysis
    3.1 World Orphan Drugs for Adults Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Orphan Drugs for Adults Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Orphan Drugs for Adults in 2022
        3.2.3 Global Concentration Ratios (CR8) for Orphan Drugs for Adults in 2022
    3.3 Orphan Drugs for Adults Company Evaluation Quadrant
    3.4 Orphan Drugs for Adults Market: Overall Company Footprint Analysis
        3.4.1 Orphan Drugs for Adults Market: Region Footprint
        3.4.2 Orphan Drugs for Adults Market: Company Product Type Footprint
        3.4.3 Orphan Drugs for Adults Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Orphan Drugs for Adults Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Orphan Drugs for Adults Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Orphan Drugs for Adults Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Orphan Drugs for Adults Consumption Value Comparison
        4.2.1 United States VS China: Orphan Drugs for Adults Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Orphan Drugs for Adults Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Orphan Drugs for Adults Companies and Market Share, 2018-2023
        4.3.1 United States Based Orphan Drugs for Adults Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Orphan Drugs for Adults Revenue, (2018-2023)
    4.4 China Based Companies Orphan Drugs for Adults Revenue and Market Share, 2018-2023
        4.4.1 China Based Orphan Drugs for Adults Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Orphan Drugs for Adults Revenue, (2018-2023)
    4.5 Rest of World Based Orphan Drugs for Adults Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Orphan Drugs for Adults Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Orphan Drugs for Adults Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Orphan Drugs for Adults Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oncology Drugs
        5.2.2 Gastrointestinal Drugs
        5.2.3 Neurology Drugs
        5.2.4 Cardio-vascular Drugs
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Orphan Drugs for Adults Market Size by Type (2018-2023)
        5.3.2 World Orphan Drugs for Adults Market Size by Type (2024-2029)
        5.3.3 World Orphan Drugs for Adults Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Orphan Drugs for Adults Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail pharmacies
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Orphan Drugs for Adults Market Size by Application (2018-2023)
        6.3.2 World Orphan Drugs for Adults Market Size by Application (2024-2029)
        6.3.3 World Orphan Drugs for Adults Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Abbvie
        7.1.1 Abbvie Details
        7.1.2 Abbvie Major Business
        7.1.3 Abbvie Orphan Drugs for Adults Product and Services
        7.1.4 Abbvie Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Abbvie Recent Developments/Updates
        7.1.6 Abbvie Competitive Strengths & Weaknesses
    7.2 Orpharma
        7.2.1 Orpharma Details
        7.2.2 Orpharma Major Business
        7.2.3 Orpharma Orphan Drugs for Adults Product and Services
        7.2.4 Orpharma Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Orpharma Recent Developments/Updates
        7.2.6 Orpharma Competitive Strengths & Weaknesses
    7.3 Amgen
        7.3.1 Amgen Details
        7.3.2 Amgen Major Business
        7.3.3 Amgen Orphan Drugs for Adults Product and Services
        7.3.4 Amgen Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Amgen Recent Developments/Updates
        7.3.6 Amgen Competitive Strengths & Weaknesses
    7.4 Recordati
        7.4.1 Recordati Details
        7.4.2 Recordati Major Business
        7.4.3 Recordati Orphan Drugs for Adults Product and Services
        7.4.4 Recordati Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Recordati Recent Developments/Updates
        7.4.6 Recordati Competitive Strengths & Weaknesses
    7.5 Novartis
        7.5.1 Novartis Details
        7.5.2 Novartis Major Business
        7.5.3 Novartis Orphan Drugs for Adults Product and Services
        7.5.4 Novartis Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Novartis Recent Developments/Updates
        7.5.6 Novartis Competitive Strengths & Weaknesses
    7.6 Celgene
        7.6.1 Celgene Details
        7.6.2 Celgene Major Business
        7.6.3 Celgene Orphan Drugs for Adults Product and Services
        7.6.4 Celgene Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Celgene Recent Developments/Updates
        7.6.6 Celgene Competitive Strengths & Weaknesses
    7.7 Amryt Pharma
        7.7.1 Amryt Pharma Details
        7.7.2 Amryt Pharma Major Business
        7.7.3 Amryt Pharma Orphan Drugs for Adults Product and Services
        7.7.4 Amryt Pharma Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Amryt Pharma Recent Developments/Updates
        7.7.6 Amryt Pharma Competitive Strengths & Weaknesses
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Details
        7.8.2 Johnson & Johnson Major Business
        7.8.3 Johnson & Johnson Orphan Drugs for Adults Product and Services
        7.8.4 Johnson & Johnson Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Johnson & Johnson Recent Developments/Updates
        7.8.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.9 GSK
        7.9.1 GSK Details
        7.9.2 GSK Major Business
        7.9.3 GSK Orphan Drugs for Adults Product and Services
        7.9.4 GSK Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 GSK Recent Developments/Updates
        7.9.6 GSK Competitive Strengths & Weaknesses
    7.10 Bristol-Myers Squibb Company
        7.10.1 Bristol-Myers Squibb Company Details
        7.10.2 Bristol-Myers Squibb Company Major Business
        7.10.3 Bristol-Myers Squibb Company Orphan Drugs for Adults Product and Services
        7.10.4 Bristol-Myers Squibb Company Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bristol-Myers Squibb Company Recent Developments/Updates
        7.10.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    7.11 Roche Holding
        7.11.1 Roche Holding Details
        7.11.2 Roche Holding Major Business
        7.11.3 Roche Holding Orphan Drugs for Adults Product and Services
        7.11.4 Roche Holding Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Roche Holding Recent Developments/Updates
        7.11.6 Roche Holding Competitive Strengths & Weaknesses
    7.12 Sanofi
        7.12.1 Sanofi Details
        7.12.2 Sanofi Major Business
        7.12.3 Sanofi Orphan Drugs for Adults Product and Services
        7.12.4 Sanofi Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Sanofi Recent Developments/Updates
        7.12.6 Sanofi Competitive Strengths & Weaknesses
    7.13 Takeda
        7.13.1 Takeda Details
        7.13.2 Takeda Major Business
        7.13.3 Takeda Orphan Drugs for Adults Product and Services
        7.13.4 Takeda Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Takeda Recent Developments/Updates
        7.13.6 Takeda Competitive Strengths & Weaknesses
    7.14 Pfizer
        7.14.1 Pfizer Details
        7.14.2 Pfizer Major Business
        7.14.3 Pfizer Orphan Drugs for Adults Product and Services
        7.14.4 Pfizer Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Pfizer Recent Developments/Updates
        7.14.6 Pfizer Competitive Strengths & Weaknesses
    7.15 Vertex Pharmaceuticals
        7.15.1 Vertex Pharmaceuticals Details
        7.15.2 Vertex Pharmaceuticals Major Business
        7.15.3 Vertex Pharmaceuticals Orphan Drugs for Adults Product and Services
        7.15.4 Vertex Pharmaceuticals Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Vertex Pharmaceuticals Recent Developments/Updates
        7.15.6 Vertex Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Orphan Drugs for Adults Industry Chain
    8.2 Orphan Drugs for Adults Upstream Analysis
    8.3 Orphan Drugs for Adults Midstream Analysis
    8.4 Orphan Drugs for Adults Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Orphan Drugs for Adults Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Orphan Drugs for Adults Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Orphan Drugs for Adults Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Orphan Drugs for Adults Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Orphan Drugs for Adults Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Orphan Drugs for Adults Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Orphan Drugs for Adults Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Orphan Drugs for Adults Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Orphan Drugs for Adults Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Orphan Drugs for Adults Players in 2022
    Table 12. World Orphan Drugs for Adults Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Orphan Drugs for Adults Company Evaluation Quadrant
    Table 14. Head Office of Key Orphan Drugs for Adults Player
    Table 15. Orphan Drugs for Adults Market: Company Product Type Footprint
    Table 16. Orphan Drugs for Adults Market: Company Product Application Footprint
    Table 17. Orphan Drugs for Adults Mergers & Acquisitions Activity
    Table 18. United States VS China Orphan Drugs for Adults Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Orphan Drugs for Adults Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Orphan Drugs for Adults Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Orphan Drugs for Adults Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Orphan Drugs for Adults Revenue Market Share (2018-2023)
    Table 23. China Based Orphan Drugs for Adults Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Orphan Drugs for Adults Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Orphan Drugs for Adults Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Orphan Drugs for Adults Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Orphan Drugs for Adults Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Orphan Drugs for Adults Revenue Market Share (2018-2023)
    Table 29. World Orphan Drugs for Adults Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Orphan Drugs for Adults Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Orphan Drugs for Adults Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Orphan Drugs for Adults Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Orphan Drugs for Adults Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Orphan Drugs for Adults Market Size by Application (2024-2029) & (USD Million)
    Table 35. Abbvie Basic Information, Area Served and Competitors
    Table 36. Abbvie Major Business
    Table 37. Abbvie Orphan Drugs for Adults Product and Services
    Table 38. Abbvie Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Abbvie Recent Developments/Updates
    Table 40. Abbvie Competitive Strengths & Weaknesses
    Table 41. Orpharma Basic Information, Area Served and Competitors
    Table 42. Orpharma Major Business
    Table 43. Orpharma Orphan Drugs for Adults Product and Services
    Table 44. Orpharma Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Orpharma Recent Developments/Updates
    Table 46. Orpharma Competitive Strengths & Weaknesses
    Table 47. Amgen Basic Information, Area Served and Competitors
    Table 48. Amgen Major Business
    Table 49. Amgen Orphan Drugs for Adults Product and Services
    Table 50. Amgen Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Amgen Recent Developments/Updates
    Table 52. Amgen Competitive Strengths & Weaknesses
    Table 53. Recordati Basic Information, Area Served and Competitors
    Table 54. Recordati Major Business
    Table 55. Recordati Orphan Drugs for Adults Product and Services
    Table 56. Recordati Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Recordati Recent Developments/Updates
    Table 58. Recordati Competitive Strengths & Weaknesses
    Table 59. Novartis Basic Information, Area Served and Competitors
    Table 60. Novartis Major Business
    Table 61. Novartis Orphan Drugs for Adults Product and Services
    Table 62. Novartis Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Novartis Recent Developments/Updates
    Table 64. Novartis Competitive Strengths & Weaknesses
    Table 65. Celgene Basic Information, Area Served and Competitors
    Table 66. Celgene Major Business
    Table 67. Celgene Orphan Drugs for Adults Product and Services
    Table 68. Celgene Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Celgene Recent Developments/Updates
    Table 70. Celgene Competitive Strengths & Weaknesses
    Table 71. Amryt Pharma Basic Information, Area Served and Competitors
    Table 72. Amryt Pharma Major Business
    Table 73. Amryt Pharma Orphan Drugs for Adults Product and Services
    Table 74. Amryt Pharma Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Amryt Pharma Recent Developments/Updates
    Table 76. Amryt Pharma Competitive Strengths & Weaknesses
    Table 77. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 78. Johnson & Johnson Major Business
    Table 79. Johnson & Johnson Orphan Drugs for Adults Product and Services
    Table 80. Johnson & Johnson Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Johnson & Johnson Recent Developments/Updates
    Table 82. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 83. GSK Basic Information, Area Served and Competitors
    Table 84. GSK Major Business
    Table 85. GSK Orphan Drugs for Adults Product and Services
    Table 86. GSK Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. GSK Recent Developments/Updates
    Table 88. GSK Competitive Strengths & Weaknesses
    Table 89. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
    Table 90. Bristol-Myers Squibb Company Major Business
    Table 91. Bristol-Myers Squibb Company Orphan Drugs for Adults Product and Services
    Table 92. Bristol-Myers Squibb Company Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bristol-Myers Squibb Company Recent Developments/Updates
    Table 94. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
    Table 95. Roche Holding Basic Information, Area Served and Competitors
    Table 96. Roche Holding Major Business
    Table 97. Roche Holding Orphan Drugs for Adults Product and Services
    Table 98. Roche Holding Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Roche Holding Recent Developments/Updates
    Table 100. Roche Holding Competitive Strengths & Weaknesses
    Table 101. Sanofi Basic Information, Area Served and Competitors
    Table 102. Sanofi Major Business
    Table 103. Sanofi Orphan Drugs for Adults Product and Services
    Table 104. Sanofi Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Sanofi Recent Developments/Updates
    Table 106. Sanofi Competitive Strengths & Weaknesses
    Table 107. Takeda Basic Information, Area Served and Competitors
    Table 108. Takeda Major Business
    Table 109. Takeda Orphan Drugs for Adults Product and Services
    Table 110. Takeda Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Takeda Recent Developments/Updates
    Table 112. Takeda Competitive Strengths & Weaknesses
    Table 113. Pfizer Basic Information, Area Served and Competitors
    Table 114. Pfizer Major Business
    Table 115. Pfizer Orphan Drugs for Adults Product and Services
    Table 116. Pfizer Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Pfizer Recent Developments/Updates
    Table 118. Vertex Pharmaceuticals Basic Information, Area Served and Competitors
    Table 119. Vertex Pharmaceuticals Major Business
    Table 120. Vertex Pharmaceuticals Orphan Drugs for Adults Product and Services
    Table 121. Vertex Pharmaceuticals Orphan Drugs for Adults Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Orphan Drugs for Adults Upstream (Raw Materials)
    Table 123. Orphan Drugs for Adults Typical Customers
List of Figure
    Figure 1. Orphan Drugs for Adults Picture
    Figure 2. World Orphan Drugs for Adults Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Orphan Drugs for Adults Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Orphan Drugs for Adults Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Orphan Drugs for Adults Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Orphan Drugs for Adults Revenue (2018-2029) & (USD Million)
    Figure 13. Orphan Drugs for Adults Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Orphan Drugs for Adults Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Orphan Drugs for Adults Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Orphan Drugs for Adults by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Orphan Drugs for Adults Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Orphan Drugs for Adults Markets in 2022
    Figure 27. United States VS China: Orphan Drugs for Adults Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Orphan Drugs for Adults Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Orphan Drugs for Adults Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Orphan Drugs for Adults Market Size Market Share by Type in 2022
    Figure 31. Oncology Drugs
    Figure 32. Gastrointestinal Drugs
    Figure 33. Neurology Drugs
    Figure 34. Cardio-vascular Drugs
    Figure 35. Others
    Figure 36. World Orphan Drugs for Adults Market Size Market Share by Type (2018-2029)
    Figure 37. World Orphan Drugs for Adults Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 38. World Orphan Drugs for Adults Market Size Market Share by Application in 2022
    Figure 39. Hospital Pharmacies
    Figure 40. Retail pharmacies
    Figure 41. Others
    Figure 42. Orphan Drugs for Adults Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Abbvie
Orpharma
Amgen
Recordati
Novartis
Celgene
Amryt Pharma
Johnson & Johnson
GSK
Bristol-Myers Squibb Company
Roche Holding
Sanofi
Takeda
Pfizer
Vertex Pharmaceuticals